H. Christian Fibiger

H. Christian Fibiger

Director/Board Member at ImStar Therapeutics, Inc.

80 year
Health Technology
Consumer Services

Profile

H.
Christian Fibiger
is currently a Director at ImStar Therapeutics, Inc., AiVita Biomedical, Inc., and GABA Therapeutics, Inc. He previously held positions as a Director at MSI Methylation Sciences, Inc., iCo Therapeutics, Inc., biOasis Technologies, Inc., Sirius Genomics, Inc., Amgen, Inc., Eli Lilly & Co., the University of British Columbia, Biovail Laboratories International SRL, HLS Therapeutics, Inc., and MedGenesis Therapeutix, Inc. He obtained a doctorate degree from Princeton University in 1970 and an undergraduate degree from the University of Victoria in 1966.

H. Christian Fibiger active positions

CompaniesPositionStart
Director/Board Member -
Director/Board Member -
Director/Board Member 04/04/2022
All active positions of H. Christian Fibiger

Former positions of H. Christian Fibiger

CompaniesPositionEnd
BIOASIS TECHNOLOGIES INC. Director/Board Member 20/09/2017
Chief Tech/Sci/R&D Officer 31/12/2016
Chief Tech/Sci/R&D Officer 31/12/2009
SATELLOS BIOSCIENCE INC. Director/Board Member 04/06/2009
AMGEN INC. Corporate Officer/Principal 31/12/2006
See the detail of H. Christian Fibiger's experience

Training of H. Christian Fibiger

Princeton University Doctorate Degree
University of Victoria Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of H. Christian Fibiger's experience

Connections

100 +

1st degree connections

15

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
AMGEN INC.

Health Technology

ELI LILLY AND COMPANY

Health Technology

BIOASIS TECHNOLOGIES INC.

Health Technology

Private companies9

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

See company connections
  1. Stock Market
  2. Insiders
  3. H. Christian Fibiger